<VariationArchive VariationID="7800" VariationName="NM_004482.4(GALNT3):c.803dup (p.Thr269fs)" VariationType="Duplication" Accession="VCV000007800" Version="3" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-20" DateCreated="2018-05-26" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="22839" VariationID="7800">
      <GeneList>
        <Gene Symbol="GALNT3" FullName="polypeptide N-acetylgalactosaminyltransferase 3" GeneID="2591" HGNC_ID="HGNC:4125" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165747588" stop="165794692" display_start="165747588" display_stop="165794692" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166604312" stop="166650802" display_start="166604312" display_stop="166650802" Strand="-" />
          </Location>
          <OMIM>601756</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004482.4(GALNT3):c.803dup (p.Thr269fs)</Name>
      <CanonicalSPDI>NC_000002.12:165761939:G:GG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165761939" stop="165761940" display_start="165761939" display_stop="165761940" variantLength="1" positionVCF="165761939" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166618449" stop="166618450" display_start="166618449" display_stop="166618450" variantLength="1" positionVCF="166618449" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <ProteinChange>T269fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.166618450dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.166618450dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.165761940dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.165761940dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012069.1" sequenceAccession="NG_012069" sequenceVersion="1" change="g.37354dup">
            <Expression>NG_012069.1:g.37354dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004482.4" sequenceAccession="NM_004482" sequenceVersion="4" change="c.803dup" MANESelect="true">
            <Expression>NM_004482.4:c.803dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004473.2" sequenceAccession="NP_004473" sequenceVersion="2" change="p.Thr269fs">
            <Expression>NP_004473.2:p.Thr269fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA212881" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="601756.0010" DB="OMIM" />
        <XRef Type="rs" ID="766750282" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 17311862 Fig. 1B to determine the location of this allele on the current reference sequence.</Comment>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00002" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00008" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004482.4(GALNT3):c.803dup (p.Thr269fs) AND Tumoral calcinosis, hyperphosphatemic, familial, 1" Accession="RCV000008243" Version="5">
        <ClassifiedConditionList TraitSetID="2115">
          <ClassifiedCondition DB="MedGen" ID="C4692564">Tumoral calcinosis, hyperphosphatemic, familial, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-04-22" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004482.4(GALNT3):c.803dup (p.Thr269fs) AND not provided" Accession="RCV003555970" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-31" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2018-05-26" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15133511</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17311862</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20358599</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2115" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3922" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">LIPOCALCINOGRANULOMATOSIS</ElementValue>
                <XRef Type="MIM" ID="211900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MORBUS TEUTSCHLAENDER</ElementValue>
                <XRef Type="MIM" ID="211900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">TEUTSCHLAENDER DISEASE, FAMILIAL</ElementValue>
                <XRef Type="MIM" ID="211900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">TUMORAL CALCINOSIS, PRIMARY HYPERPHOSPHATEMIC</ElementValue>
                <XRef Type="MIM" ID="211900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperostosis-hyperphosphatemia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperostosis with hyperphosphatemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cortical hyperostosis with hyperphosphatemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tumoral calcinosis, hyperphosphatemic, familial, 1</ElementValue>
                <XRef ID="MONDO:0100252" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CALCINOSIS, TUMORAL, WITH HYPERPHOSPHATEMIA</ElementValue>
                <XRef Type="MIM" ID="211900" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HFTC</ElementValue>
                <XRef Type="MIM" ID="211900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HFTC1</ElementValue>
                <XRef Type="MIM" ID="211900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HHS</ElementValue>
                <XRef Type="MIM" ID="211900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PHPTC</ElementValue>
                <XRef Type="MIM" ID="211900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hyperphosphatemic familial tumoral calcinosis (HFTC) is characterized by: Ectopic calcifications (tumoral calcinosis) typically found in periarticular soft tissues exposed to repetitive trauma or prolonged pressure (e.g., hips, elbows, and shoulders); and Painful swellings (referred to as hyperostosis) in the areas overlying the diaphyses of the tibiae (and less often the ulna, metacarpal bones, and radius). The dental phenotype unique to HFTC includes enamel hypoplasia, short and bulbous roots, obliteration of pulp chambers and canals, and pulp stones. Less common are large and small vessel calcifications that are often asymptomatic incidental findings on radiologic studies but can also cause peripheral vascular insufficiency (e.g., pain, cold extremities, and decreased peripheral pulses). Less frequently reported findings include testicular microlithiasis and angioid streaks of the retina.</Attribute>
                <XRef ID="NBK476672" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15146" />
                <XRef ID="15146" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29389098</ID>
                <ID Source="BookShelf">NBK476672</ID>
              </Citation>
              <XRef ID="53715" DB="Orphanet" />
              <XRef ID="C4692564" DB="MedGen" />
              <XRef ID="MONDO:0100252" DB="MONDO" />
              <XRef Type="MIM" ID="211900" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="28450" SubmissionDate="2018-05-23" DateLastUpdated="2018-05-26" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="601756.0010_TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1" title="GALNT3, 1-BP INS, 803C_TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1" />
        <ClinVarAccession Accession="SCV000028450" DateUpdated="2018-05-26" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 5-year-old French boy with hyperostosis-hyperphosphatemia syndrome (HFTC1; 211900), Ichikawa et al. (2007) identified compound heterozygosity for 2 mutations in the GALNT3 gene: a 1-bp insertion (803_804insC) in exon 3, and a splice site mutation, IVS8+1G-A (601756.0011). The boy presented with painful cortical lesions in his leg, and radiographs of the affected bone showed diaphyseal hyperostosis. The lesional tissue comprised trabeculae of immature, woven bone surrounded by fibrous tissue. Intact FGF23 level in the patient was low normal, whereas C-terminal FGF23 was elevated, a pattern similar that in tumoral calcinosis. The patient's parents and brother were heterozygous for one of the mutations and had no biochemical abnormalities. Ichikawa et al. (2007) suggested that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are different manifestations of the same disorder.</Attribute>
              <Citation>
                <ID Source="PubMed">17311862</ID>
              </Citation>
              <XRef DB="OMIM" ID="211900" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALNT3" />
          </GeneList>
          <Name>GALNT3, 1-BP INS, 803C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 803C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601756.0010" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5458307" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_004482.4:c.803dup|OMIM:211900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002811732" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004482.4:c.803dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="211900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7978296" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4834069|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004293413" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15133511</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20358599</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17311862</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Thr269Asnfs*3) in the GALNT3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GALNT3 are known to be pathogenic (PMID: 15133511, 20358599). This variant is present in population databases (rs766750282, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with clinical features of GALT1-related disorders (PMID: 17311862). ClinVar contains an entry for this variant (Variation ID: 7800). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALNT3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.166618449_166618450insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5458307" TraitType="Disease" MappingType="XRef" MappingValue="211900" MappingRef="OMIM">
        <MedGen CUI="C4692564" Name="Tumoral calcinosis, hyperphosphatemic, familial, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="28450" TraitType="Disease" MappingType="Name" MappingValue="TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1" MappingRef="Preferred">
        <MedGen CUI="C4692564" Name="Tumoral calcinosis, hyperphosphatemic, familial, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7978296" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

